Study: Treatments for Hep C Improving

June 14, 2002

WASHINGTON, D.C. - A committee convened by the National Institutes of Health (NIH) has found that treatment for the hepatitis C virus (HCV) has significantly improved during the past five years.

Influenza Antiviral Reduces Infection Rate

December 27, 2001

CHICAGO-Researchers at the Interscience Conference on Antimicrobial Agents and Chemotherpay (ICAAC) reported a new influenza medication limits the spread of the infectious disease within households.

Hep C May Kill More than AIDS

August 15, 2001

ATLANTA, Ga-Officials from the Centers for Disease Control and Prevention (CDC) estimated that the hepatitis C virus (HCV) will be more lethal than AIDS by 2010.

FDA Approves Hepatitis C Drug

July 27, 2001

WASHINGTON, DC-Officials from the Food and Drug Administration (FDA) approved a Shering-plough Corporation hepatitis C drug could be packaged and marketed alone for the first time.

Hepatitis C: An Update

July 11, 2001

It's often portrayed as a virus causing an incurable disease--a killer with few outward warning signs that lurks inside the body and slowly ravages the liver.

Antiretroviral Therapy May Trigger Oral Warts

May 7, 2001

LONDON-A new study from researchers at the University of California San Francisco has found that HIV patients who use highly active antiretroviral therapy (HAART) are six times more likely to develop oral warts than untreated patients.

New Version of Hepatitis C Drug More Effective

December 8, 2000

Doctors are hopeful a new version of a drug could help hepatitis C sufferers. Two studies, sponsored by the drug maker Hoffmann-La Roche Inc, tested a modified form of interferon called Pegasys against the standard Roferon-A.